Paal-Beringen, Belgium

Koen Vandyck

USPTO Granted Patents = 44 

 

 

Average Co-Inventor Count = 4.6

ph-index = 9

Forward Citations = 298(Granted Patents)


Location History:

  • Mechelen, BE (2013)
  • Paal-Beringen, BE (2013 - 2021)
  • Paal-Beringer, BE (2021)
  • Paal, BE (2021 - 2024)
  • Beringen, BE (2021 - 2024)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
44 patents (USPTO):

Title: Innovations of Koen Vandyck: A Pioneer in Patent Development

Introduction

Koen Vandyck, based in Paal-Beringen, Belgium, is an accomplished inventor with a remarkable portfolio of 43 patents. His contributions to the field of pharmaceutical science have led to significant advancements in the treatment of various diseases. Vandyck's work exemplifies the innovative spirit that drives change and development within the industry.

Latest Patents

Among Koen Vandyck's most recent patents are two notable innovations. The first is centered around "Modulators of THR-β and methods of use thereof." This patent involves compounds of a specific formula that can potentially treat diseases by administering or contacting a patient with these compounds, showcasing Vandyck's commitment to addressing critical health issues through advanced pharmacological methods.

The second patent focuses on "Anti-viral compounds." This involves similar compound formulations and pharmaceutical compositions that are capable of treating various diseases and conditions. These innovations highlight his ongoing dedication to developing effective therapeutics and improving healthcare outcomes.

Career Highlights

Throughout his career, Koen Vandyck has worked with reputable companies, including Janssen Sciences Ireland Uc and Aligos Therapeutics, Inc. His experience at these organizations has allowed him to collaborate with some of the leading minds in the pharmaceutical industry, solidifying his expertise and impact on drug development.

Collaborations

In his professional journey, Vandyck has partnered with esteemed colleagues such as Pierre Jean-Marie Bernard Raboisson and Stefaan Julien Last. These collaborations have led to synergistic advancements in research, further enriching the pharmaceutical landscape. Working alongside such talented individuals fosters an environment of innovation and progression that benefits the industry as a whole.

Conclusion

Koen Vandyck's impressive array of patents and contributions to pharmaceutical research underscore his role as a significant figure in the field of innovations and inventions. His work not only demonstrates his expertise but also reflects the potential to change lives through effective treatments. As he continues to develop new compounds and methods, the impact of his innovations will undoubtedly resonate within the healthcare community for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…